This treatment can cause an infusion reaction. It's like an allergic reaction. It often happens while the medicine is being given. Or it may occur just after. Symptoms are usually mild and may include:
- Chills.
- A fever.
- Nausea.
- Flushing of your face.
- A rash.
- Headaches.
Rarely, more serious side effects may happen while the medicine is being given. These include:
- Low blood pressure.
- Chest tightness.
- Wheezing and trouble breathing.
You may be given medicines before your infusion to help lower the risk of these problems. Tell your doctor right away if you have any of these symptoms during or soon after your infusion.
Other side effects depend on which medicine is given and other factors. It's very important to tell your doctors about any changes you notice while you're getting treated with monoclonal antibody therapy.
Brentuximab vedotin can cause side effects such as:
- Nerve damage (neuropathy).
- Feeling very tired.
- Low blood cell counts.
- Nausea and vomiting.
- Fever.
- Infections.
- Diarrhea.
Rituximab may cause a severe infusion-related reaction during the first infusion. But it's not common for the infusion reaction to occur with the next infusions of rituximab. This medicine can raise your risk for infection in the months after treatment. If you have been infected with the hepatitis B virus in the past, the virus may become active again. Your doctor will likely test your blood for hepatitis B before you start this medicine.
Nivolumab and pembrolizumab can cause these side effects:
- Feeling very tired
- Cough
- Skin rash
- Joint pain
- Loss of appetite
- Bowel problems (constipation or diarrhea)
Because these medicines kill cancer cells by taking the brakes off the immune system, sometimes the immune system starts attacking other parts of the body. This can lead to serious problems with the lungs, kidneys, liver, and other organs.